UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The New England journal of medicine, ISSN 0028-4793, 06/2016, Volume 374, Issue 23, pp. 2222 - 2234
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Glycopyrrolate - adverse effects | Indans - adverse effects | Pulmonary Disease, Chronic Obstructive - mortality | Glucocorticoids - therapeutic use | Double-Blind Method | Glycopyrrolate - therapeutic use | Humans | Middle Aged | Administration, Inhalation | Male | Fluticasone-Salmeterol Drug Combination - therapeutic use | Muscarinic Antagonists - therapeutic use | Indans - therapeutic use | Fluticasone-Salmeterol Drug Combination - adverse effects | Quinolones - adverse effects | Quinolones - therapeutic use | Adrenergic beta-2 Receptor Agonists - therapeutic use | Female | Aged | Drug Combinations | Pulmonary Disease, Chronic Obstructive - drug therapy | Lung diseases, Obstructive | Care and treatment | Indacaterol | Dosage and administration | Salmeterol | Respiratory therapy | Acetylcholine receptors (muscarinic) | Glucocorticoids | Lung diseases | Fluticasone | Preventive medicine | Patients | Inhalation | Obstructive lung disease | Comparative studies | Chronic obstructive pulmonary disease | Pharmaceuticals | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2007, Volume 370, Issue 9589, pp. 786 - 796
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Public health. Hygiene-occupational medicine | Public health. Hygiene | General aspects | Prevention and actions | Biological and medical sciences | Medical sciences | Chronic obstructive pulmonary disease, asthma | Pneumology | Bronchodilator Agents - therapeutic use | Severity of Illness Index | Phosphodiesterase Inhibitors - therapeutic use | Bacterial Infections - etiology | Humans | Hospitalization - statistics & numerical data | Pulmonary Disease, Chronic Obstructive - classification | Pulmonary Disease, Chronic Obstructive - physiopathology | Adrenal Cortex Hormones - therapeutic use | Randomized Controlled Trials as Topic | Bacterial Infections - prevention & control | Pulmonary Disease, Chronic Obstructive - therapy | Exercise | Hospitalization - economics | Prevention | Causes of | Lung diseases, Obstructive | Research | Studies | Changes | Plasma | Hospitals | Oxygen therapy | Antibiotics | Mortality | Diagnostic tests | Chronic obstructive pulmonary disease | Infections | Index Medicus | Abridged Index Medicus
Journal Article
3.
Management of COPD exacerbations: A European Respiratory Society/American Thoracic Society guideline
The European respiratory journal, ISSN 0903-1936, 10/2017, Volume 50, Issue 4, pp. 1600791 - 1600791
Life Sciences & Biomedicine | Respiratory System | Science & Technology | Bronchodilator Agents - therapeutic use | United States | Europe | Humans | Hospitalization | Respiratory Insufficiency - therapy | Adrenal Cortex Hormones - therapeutic use | Disease Progression | Noninvasive Ventilation | Pulmonary Disease, Chronic Obstructive - therapy | Societies, Medical | Pulmonary Disease, Chronic Obstructive - rehabilitation | Disease Management | Corticoids | Task forces | Intravenous administration | Antibiotics | Lung diseases | Obstructive lung disease | Ventilation | Chronic obstructive pulmonary disease | Thorax | Rehabilitation | Management
Journal Article
Respiratory research, ISSN 1465-9921, 06/2010, Volume 11, Issue 1, pp. 88 - 88
Journal Article
American journal of respiratory and critical care medicine, ISSN 1073-449X, 09/2016, Volume 194, Issue 5, pp. 527 - 528
Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Phosphodiesterase Inhibitors | Cyclic Nucleotide Phosphodiesterases, Type 4 | Humans | Pulmonary Disease, Chronic Obstructive | Disease Progression | Phosphodiesterase 4 Inhibitors | Index Medicus | Abridged Index Medicus
Journal Article
BMC medicine, ISSN 1741-7015, 08/2013, Volume 11, Issue 1, pp. 181 - 181
Frequent exacerbator phenotype | Chronic obstructive pulmonary disease (COPD) | Exacerbations | Comorbidities | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Severity of Illness Index | Pulmonary Disease, Chronic Obstructive - diagnosis | Phenotype | Forced Expiratory Volume - physiology | Humans | Quality of Life | Pulmonary Disease, Chronic Obstructive - physiopathology | Patient Admission - trends | Pulmonary Disease, Chronic Obstructive - genetics | Gastroesophageal reflux | Medical research | Lung diseases, Obstructive | Comorbidity | Medicine, Experimental | Development and progression | United Kingdom | Health aspects | Risk factors | Diseases | Chronic obstructive pulmonary disease | Bone density | Drug therapy | Patients | Viral infections | Index Medicus
Journal Article
American journal of respiratory and critical care medicine, ISSN 1073-449X, 01/2017, Volume 195, Issue 1, pp. 1 - 3
Journal Article
American journal of respiratory and critical care medicine, ISSN 1073-449X, 05/2016, Volume 193, Issue 9, pp. 937 - 938
Journal Article
American journal of respiratory and critical care medicine, ISSN 1073-449X, 08/2015, Volume 192, Issue 4, pp. 523 - 525
Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Formoterol Fumarate | Glucocorticoids - therapeutic use | Double-Blind Method | Humans | Treatment Outcome | Biomarkers - blood | Pulmonary Disease, Chronic Obstructive - complications | Pulmonary Disease, Chronic Obstructive - blood | Adrenergic beta-2 Receptor Agonists - therapeutic use | Ethanolamines - therapeutic use | Leukocyte Count | Beclomethasone - therapeutic use | Drug Therapy, Combination | Eosinophils | Pulmonary Disease, Chronic Obstructive - drug therapy | Index Medicus | Abridged Index Medicus | Correspondence
Journal Article
The New England journal of medicine, ISSN 0028-4793, 09/2017, Volume 377, Issue 10, pp. 986 - 987
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Mucus | Humans | Pulmonary Disease, Chronic Obstructive | Mucins | Lung diseases, Obstructive | Analysis | Research | Diagnosis | Biological markers | Health aspects | Airway (Medicine) | Respiratory tract | Airway management | Hypotheses | Middle age | Lung diseases | Obstructive lung disease | Biomarkers | Chronic obstructive pulmonary disease | Inflammation | Patients | Asthma | Smoking | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 09/2019, Volume 381, Issue 13, pp. 1257 - 1266
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Pulmonary Disease, Chronic Obstructive - diagnosis | Pulmonary Disease, Chronic Obstructive - therapy | Prevalence | Humans | Adrenergic beta-Agonists - therapeutic use | Muscarinic Antagonists - therapeutic use | Oxygen Inhalation Therapy | Pulmonary Disease, Chronic Obstructive - epidemiology | Causes of | Lung diseases, Obstructive | Care and treatment | Genetic aspects | Diagnosis | Low income groups | Genotype & phenotype | Clinical aspects | Dyspnea | Pathogenesis | Lung cancer | Mortality | Lung diseases | Obstructive lung disease | Chronic obstructive pulmonary disease | Emphysema | Smoking | Index Medicus | Abridged Index Medicus
Journal Article